Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis-Specific Transcriptional Signatures in Human Skin.

Autor: Trinh-Minh T; University Hospital Düsseldorf and Heinrich-Heine University, Düsseldorf, Germany., Györfi AH; University Hospital Düsseldorf and Heinrich-Heine University, Düsseldorf, Germany., Tomcik M; Charles University, Prague, Czech Republic., Tran-Manh C; University Hospital Düsseldorf and Heinrich-Heine University, Düsseldorf, Germany., Zhou X; University Hospital Düsseldorf and Heinrich-Heine University, Düsseldorf, Germany., Dickel N; Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany., Tümerdem BS; University Hospital Düsseldorf and Heinrich-Heine University, Düsseldorf, Germany., Kreuter A; Helios St. Elisabeth Klinik Oberhausen, University Witten-Herdecke, Oberhausen, and Helios St. Johannes Klinik Duisburg, Duisburg, Germany., Burmann SN; Helios St. Elisabeth Klinik Oberhausen, University Witten-Herdecke, Oberhausen, Germany., Borchert SV; Arxx Therapeutics, Oslo, Norway, and Roskilde University, Roskilde, Denmark., Hussain RI; Agiana Pharmaceuticals, Oslo, Norway., Hallén J; Arxx Therapeutics, Oslo, Norway., Klingelhöfer J; Arxx Therapeutics, Oslo, Norway., Kunz M; Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany., Distler JHW; University Hospital Düsseldorf and Heinrich-Heine University, Düsseldorf, Germany.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 May; Vol. 76 (5), pp. 783-795. Date of Electronic Publication: 2024 Feb 15.